DocGo Stock

DocGo EBITDA Margin

The EBITDA Margin of DocGo (DCGO) as of Aug 8, 2026 is 7.23 %. In the previous year, EBITDA Margin was 5.09 % — a change of 42.14% (higher).

EBITDA Margin

7.23 %

YoY

42.14%

Last updated:

EBITDA Margin of DocGo is 2026 7.23 % . EBITDA Margin of DocGo was 2025 5.09 % . It decreases by 42.14% higher compared to the previous year.
Access this data via the Eulerpool API

DocGo Stock analysis

What does DocGo do? The history of DocGo Inc began in 2014 when the idea was born to develop a mobile app for doctor appointment scheduling and health monitoring. The founders recognized a rising demand for faster and more convenient access to medical services. From this vision, DocGo Inc was created. DocGo Inc's business model includes a range of mobile applications that improve access to medical care. The main application is DocGo, which allows users to book doctor appointments and track and manage their health data. This app also offers a feature for monitoring chronic conditions such as diabetes or high blood pressure and automatically sends reports on the status of these conditions to the user's doctor. Another important product from DocGo is the telemedicine system, which allows users to receive early assessments and diagnoses from doctors through video and chat. This helps avoid many cases where patients need to physically visit a doctor, saving time and money. DocGo has also developed a mobile pharmacy app that allows patients to order their medications directly through the app and have them delivered to their homes. This app also has interactive features such as a reminder function that notifies the user when to take their medications. Another important aspect of DocGo is its integration with wearables, which allows users to measure and send their health data to the app in real time. DocGo also utilizes artificial intelligence and machine learning to identify health risks in users and provide recommendations for medications and treatments. In recent years, DocGo has expanded in various areas. The company has formed partnerships with major healthcare organizations and hospitals to create a broader network of care. DocGo has also developed an API that allows other companies to integrate their health data into the DocGo system. Overall, DocGo has made a significant contribution to improving access to medical care, particularly during the COVID-19 pandemic. By providing telemedicine and mobile pharmacy services, as well as managing health data, DocGo has helped democratize and enhance healthcare. DocGo is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DocGo stock

EBITDA Margin of DocGo is 7.23 % in 2026.

EBITDA Margin of DocGo changed from 5.09 % to 7.23 %, representing a 42.14% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin DocGo since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's DocGo with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API

Margins — DocGo

All Key Metrics — DocGo